An increase in complaints of higher than normal patient results, some from the healthy population range to above the diagnostic cutoff for an Acute Myocardial Infarction.
Source facts
Action
Recalled by telephone calls on 3/26/04 and a follow-up letter dated 3/25/04. The accounts were informed of the elevated patient results for the Troponin-I Reagent lots, and were requested to discontinue use and destroy any of the four affected lots found in inventory.
Initiated
2004-03-26
Root cause
Other
Terminated
2004-10-14
Distribution
Nationwide and internationally to Abbott affiliates in Argentina, Canada, Germany, Singapore, Hong Kong,
Taiwan, Australia, New Zealand, Thailand, China and Korea.
Recall number
Z-0782-04
Recall status
Terminated
CDRH record ID
32282
FDA classified
2004-07-20
Recall event number
28649
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.